Acceptability of biologic treatments to patients undergoing rotator cuff repair
Based upon these survey responses, the biologic treatment options most acceptable to patients would be a pill or injection, administered for up to 3 months after surgery, with fewer than 10% of patients experiencing side effects. Most patients were willing to undergo a biologic treatment even if it only increased their likelihood of success by 10%. Therefore, based on these results, researchers and physicians developing biologic treatments could focus on avenues that only slightly increase success rates and can be administered within 3 months of surgery provided there is a favorable side effect profile.
Authors
- Christopher D. Joyce (ORCID: https://orcid.org/0000-0003-2329-5334)
- James M. Hotaling (ORCID: https://orcid.org/0000-0002-4401-4565)
- Brandon Wilde (ORCID: https://orcid.org/0000-0002-8477-0461)
- Peter N. Chalmers (ORCID: https://orcid.org/0000-0002-1275-0285)
- Corrine Kolka Welt (ORCID: https://orcid.org/0000-0002-8219-5504)
- Robert Z. Tashjian (ORCID: https://orcid.org/0000-0003-4112-0423)
Institutions
- University of Utah (US)
Publication Details
- Journal
- JSES Reviews Reports and Techniques
- Published
- 2025-03-09
- DOI
- https://doi.org/10.1016/j.xrrt.2025.02.002
- Primary Topic
- Shoulder Injury and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00